Universe Pharmaceuticals (NYSE:UPC) Shares Down 6.1% – Here’s Why

Universe Pharmaceuticals INC (NYSE:UPC)’s share price dropped 6.1% during mid-day trading on Tuesday . The stock traded as low as $0.14 and last traded at $0.16. Approximately 1,806,553 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 7,264,415 shares. The stock had previously closed at $0.17.

Universe Pharmaceuticals Trading Down 6.1 %

The business’s 50 day moving average is $0.51 and its 200 day moving average is $11.92.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC purchased a new position in shares of Universe Pharmaceuticals INC (NYSE:UPC) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned about 6.46% of Universe Pharmaceuticals as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 0.18% of the company’s stock.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.